Chlorogenic Acid Inhibits the Replication and Viability of Enterovirus 71 In Vitro

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Li, Xiang ^a   Liu, Yuanyuan ^b   Hou, Xueling ^a   Peng, Hongjun ^a   Zhang, Li ^a   Jiang, Qingbo ^a   Shi, Mei ^a   Ji, Yun ^a   Wang, Yuyue ^a   Shi, Weifeng ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROGENIC ACID; GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN 3C; PROTEIN 3D; PROTEIN VP1; PROTEINASE; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN; CELL STRAIN RD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS VIABILITY;

CHEMOKINE CCL2; CHLOROGENIC ACID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INHIBITORY CONCENTRATION 50; INTERFERON-GAMMA; INTERLEUKIN-6; MICROBIAL VIABILITY; MOLECULAR STRUCTURE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 84884749871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076007     Document Type: Article

References (37)

1. Wong SS, Yip CC, Lau SK, Yuen KY, (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138: 1071-1089. doi:10.1017/S0950268809991555. PubMed: 20056019.
2. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778-790. doi:10.1016/S1473-3099(10)70194-8. PubMed: 20961813.
3. Hsu CH, Lu CY, Shao PL, Lee PI, Kao CL, et al. (2011) Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect 44: 265-273. doi:10.1016/j.jmii.2011.01.029. PubMed: 21524954.
4. Irani DN, (2008) Aseptic meningitis and viral myelitis. Neurol Clin 26: 635-655. doi:10.1016/j.ncl.2008.03.003. PubMed: 18657719.
5. Lei X, Liu X, Ma Y, Sun Z, Yang Y, et al. (2010) The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84: 8051-8061. doi:10.1128/JVI.02491-09. PubMed: 20519382.
6. Hung H-C, Chen T-C, Fang M-Y, Yen K-J, Shih S-R, et al. (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chem 65: 676-683. doi:10.1093/jac/dkp502. PubMed: 20089540.
7. Akahata W, Yang Z-Y, Andersen H, Sun S, Holdaway HA, et al. (2010) A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 16: 334-338. doi:10.1038/nm.2105. PubMed: 20111039.
8. Kleymann G, (2003) Novel agents and strategies to treat herpes simplex virus infections. Expert Opin Investig Drugs 12: 165-183. doi:10.1517/13543784.12.2.165. PubMed: 12556212.
9. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, et al. (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLOS Pathog 6: e1001227. PubMed: 21187913.
10. Olivier AK, Gallup JM, Geelen AV, Ackermann MR, (2011) Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res 37: 131-143. doi:10.3109/01902148.2010.484518. PubMed: 21309731.
11. Wu KX, Ng MM-L, Chu JJ, (2010) Developments towards antiviral therapies against enterovirus 71. Drug Discov Today 15: 1041-1051. doi:10.1016/j.drudis.2010.10.008. PubMed: 20974282.
12. Qi W, Zhao T, Yang W-W, Wang G-H, Yu H, et al. (2011) Comparative pharmacokinetics of chlorogenic acid after oral administration in rats. J Pharm Anal 1: 270-274. doi:10.1016/j.jpha.2011.09.006.
13. McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG, et al. (1998) Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob Agents Chemother 42: 140-146. PubMed: 9449274.
14. Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC, (2002) Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res 55: 53-62. doi:10.1016/S0166-3542(02)00007-4. PubMed: 12076751.
15. Lückemeyer DD, Müller VD, Moritz MI, Stoco PH, Schenkel EP, et al. (2012) Effects of Ilex paraguariensis A. St. Hil. (yerba mate) on herpes simplex virus types 1 and 2 replication. Phytother Res 26: 535-540. doi:10.1002/ptr.3590. PubMed: 21915933.
16. Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, et al. (2011) Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med 28: 595-598. PubMed: 21725588.
17. De Francesco R, Carfí A, (2007) Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv Drug Deliv Rev 59: 1242-1262. doi:10.1016/j.addr.2007.04.016. PubMed: 17869377.
18. Sampath A, Padmanabhan R, (2009) Molecular targets for flavivirus drug discovery. Antiviral Res 81: 6-15. doi:10.1016/j.antiviral.2008.08.004. PubMed: 18796313.
19. Shang L, Xu M, Yin Z, (2013) Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res 97: 183-194. doi:10.1016/j.antiviral.2012.12.005. PubMed: 23261847.
20. Brown BA, Oberste MS, Alexander JP Jr., Kennett ML, Pallansch MA, (1999) Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73: 9969-9975. PubMed: 10559310.
21. Hsu B-M, Chen C-H, Wan M-T, (2007) Genetic diversity of epidemic enterovirus 71 strains recovered from clinical and environmental samples in Taiwan. Virus Res 126: 69-75. doi:10.1016/j.virusres.2007.01.018. PubMed: 17363101.
22. Lin T-Y, Liu Y-C, Jheng J-R, Tsai H-P, Jan J-T, et al. (2009) Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med 37: 143-158. doi:10.1142/S0192415X09006734. PubMed: 19222118.
23. Lin C-W, Wu C-F, Hsiao N-W, Chang C-Y, Li S-W, et al. (2008) Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents 32: 355-359. doi:10.1016/j.ijantimicag.2008.04.018. PubMed: 18701259.
24. Wu B-W, Pan T-L, Leu Y-L, Chang Y-K, Tai P-J, et al. (2007) Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med 35: 153-168. doi:10.1142/S0192415X07004709. PubMed: 17265559.
25. Superti F, Ammendolia MG, Marchetti M, (2008) New advances in anti-HSV chemotherapy. Curr Med Chem 15: 900-911. doi:10.2174/092986708783955419. PubMed: 18473797.
26. Khan MT, Ather A, Thompson KD, Gambari R, (2005) Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res 67: 107-119. doi:10.1016/j.antiviral.2005.05.002. PubMed: 16040137.
27. Tamura H, Akioka T, Ueno K, Chujyo T, Okazaki K, et al. (2006) Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves. Mol Nutr Food Res 50: 396-400. doi:10.1002/mnfr.200500216. PubMed: 16598806.
28. Wang G-F, Shi L-P, Ren Y-D, Liu Q-F, Liu H-F, et al. (2009) Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res 83: 186-190. doi:10.1016/j.antiviral.2009.05.002. PubMed: 19463857.
29. Rivas-Aravena A, Vallejos-Vidal E, Cortez-San Martin M, Reyes-Lopez F, Tello M, et al. (2011) Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol 85: 8037-8045. doi:10.1128/JVI.00533-11. PubMed: 21653663.
30. Bougie I, Bisaillon M, (2004) The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem 279: 22124-22130. doi:10.1074/jbc.M400908200. PubMed: 15037606.
31. Chen X, Zhang Q, Li J, Cao W, Zhang JX, et al. (2010) Analysis of recombination and natural selection in human enterovirus 71. Virology 398: 251-261. doi:10.1016/j.virol.2009.12.007. PubMed: 20060995.
32. Kuo R-L, Kung S-H, Hsu Y-Y, Liu W-T, (2002) Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol 83: 1367-1376. PubMed: 12029152.
33. Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, et al. (2000) Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol 20: 1271-1277. doi:10.1128/MCB.20.4.1271-1277.2000. PubMed: 10648613.
34. Morrison JM, Racaniello VR, (2009) Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol 83: 4412-4422. doi:10.1128/JVI.02177-08. PubMed: 19211759.
35. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, et al. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282: 2871-2879. PubMed: 17132626.
36. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J Immunol 160: 3513-3521. PubMed: 9531313.
37. Gong X, Zhou J, Zhu W, Liu N, Li J, et al. (2012) Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC Infect Dis 12: 224. doi:10.1186/1471-2334-12-224. PubMed: 22994237.